Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2020, Wilbe operates in the United States and Europe, focusing on funding scientists and engineers. The firm provides initial checks ranging from $100,000 to $500,000 and has backed 11 companies to date. Their platform combines business expertise, community support, lab space access, and capital for emerging ventures.
Wilbe invests in early-stage companies launched by scientists and engineers across various sectors, including biotech, healthcare, energy, and fintech. Their investment strategy emphasizes supporting ventures that emerge from their platform or weekly cohorts, primarily in North America and Europe.
Notable portfolio companies include Apoha (advanced materials, London, UK), Proxima Fusion (fusion energy, Munich, Germany), and Infinitopes (cancer vaccines, Oxford, UK). Other companies include Milvus Advanced (material science, Oxford, UK) and Pavakah Energy (solar energy, Hyderabad, India).
Submit your pitch through their form at https://app.wilbe.com.
Wilbe typically participates in early-stage funding rounds, often leading investments in companies that align with their focus on science and engineering.
Wilbe is open to follow-on investments, particularly for companies that demonstrate significant progress and alignment with their investment thesis.
Wilbe's fund size is not publicly disclosed, but they provide initial checks between $100,000 and $500,000 for early-stage ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.